Bright Green Corporation (BGXXQ) vs TherapeuticsMD, Inc. (TXMD)

Bright Green Corporation and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. TherapeuticsMD, Inc. is the larger, with a market value of $24.7M against $13.9M — 1.8× the size. Bright Green Corporation has the higher net margin (0.00% vs −6.64%) and the lower return on invested capital (−39.4% vs −13.8%). Across the 13 metrics below, TherapeuticsMD, Inc. leads on 9 and Bright Green Corporation on 4.

Valuation

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m 7.26 2.25
P/B n/m 0.87 1.90
Price to free cash flow n/m 8.72 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 6.95 2.56
Earnings yield 0.00% (1.14%) (2.99%)
Free cash flow yield 0.00% 11.47% 0.00%

Profitability

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 100.00% 53.94%
Operating margin 0.00% (120.89%) 0.00%
Net margin 0.00% (6.64%) 0.00%
Free cash flow margin 0.00% 94.71% 0.00%
Return on equity (73.60%) (0.80%) (0.40%)
Return on assets (44.80%) (0.57%) (3.32%)
Return on invested capital (39.35%) (13.77%) 0.00%

Growth

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 27.78% 10.01%
EPS growth (last fiscal year) 58.82% 73.68% —
Revenue growth, 5-year CAGR — (45.84%) 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.00 0.05
Current ratio 0.01 3.22 2.31
Net debt to EBITDA (0.02) 2.34 0.85

Dividend

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric BGXXQ TXMD Drug Manufacturers Specialty & Generic median
Market cap 13.88m 24.65m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack